Why Zscaler Stock Plummeted This Week

Zscaler reported fiscal Q3 adjusted EPS of $1.08 on revenue of $850.48 million, beating Wall Street estimates by $0.07 per share and $14.82 million in sales, respectively. Management raised fiscal 2026 revenue guidance to $3.3295 billion-$3.3325 billion and ARR guidance to $3.740 billion-$3.749 billion, but also signaled growth deceleration to 16%-17% in fiscal 2027. Despite the beat and raised outlook, the stock fell 18.3% for the week and is down roughly 49% over the past year.

Analysis

The market is reacting less to the quarter than to the forward deceleration signal. In high-multiple software, a guide that implies growth stepping down from the mid-20s to the mid-teens usually compresses EV/ARR multiples before fundamentals actually roll over, because the stock is priced on next-year scarcity of growth rather than current-year execution. That makes the post-print selloff less about a missed quarter and more about investors de-rating the terminal growth assumption embedded in the name.

Second-order, this is a read-through for the broader cybersecurity cohort: the bar for premium multiple expansion just moved higher, and any vendor with a similar “durable growth” narrative is now more vulnerable to scrutiny around booking quality, seat expansion, and billings conversion. If ZS is the first large-cap security platform to telegraph a slower growth regime, peers that trade on rule-of-40 optics rather than near-term FCF may see sympathy multiple pressure over the next 1-3 reporting cycles, especially if enterprise buying remains budget-gated.

The contrarian angle is that the move may already be doing part of the work for you. A ~50% drawdown over 12 months can create a valuation reset where incremental bad news matters less, and any proof that deceleration is orderly—not demand destruction—could spark a sharp re-rating. The key catalyst window is the next 1-2 quarters: if remaining performance obligations, net retention, or new product attach rates stabilize, the market can quickly pivot from “growth is slowing” to “durable platform at a fairer multiple.”

The risk is that this is not just normalization but a sign that the company has exhausted the easiest budget share gains, which would push the stock into a long dead-money phase. In that case, the better expression is not outright long exposure but a relative-value trade versus faster-growing infrastructure security names or cash-generative software with less guidance risk. The right question is whether ZS is transitioning from premium growth compounder to quality value software; if so, the multiple can keep compressing even while revenue still grows above 20%.

Key Decisions for Investors

• Avoid buying ZS into the first reaction bounce; wait for the next earnings cycle or a stabilization in growth indicators before taking risk, because the market is likely to keep de-rating the multiple over the next 1-2 quarters.
• Pair trade: long a faster-growing cybersecurity peer basket vs short ZS for 1-3 months, expressing the view that the market will reward names with less guidance deceleration and punish those with similar valuation stretch.
• If taking a contrarian long, use staged entry in ZS over 4-8 weeks and hedge with put spreads; target a rebound only if management can show stable bookings/retention, with asymmetric upside from sentiment repair but capped near-term due to multiple compression risk.
• Watch the next quarter for RPO, billings, and net retention inflection; if those flatten, reduce exposure immediately because the stock could enter a multi-quarter de-rating phase despite continued top-line growth.